MKI67 and breast carcinoma: Activation of human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), progesterone receptor (PR), proliferation marker Ki67, and/or mutations in the Breast Cancer (BRCA) gene, has been utilized in the histological and molecular characterization of breast cancer.